Rituximab Therapy in Cutaneous Infiltration of Chronic Lymphocytic Leukaemia

Publisher： Karger

E-ISSN： 1421-9662|130|1|47-51

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.1, 2013-02, pp. : 47-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Secondary Cutaneous Infiltration in B Cell Chronic Lymphocytic Leukemia

By  

Acta Haematologica, Vol. 103, Iss. 2, 2000-05 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

Fludarabine, cyclophosphamide, and multiple‐dose rituximab as frontline therapy for chronic lymphocytic leukemia

By  

CANCER, Vol. 121, Iss. 21, 2015-11 ,pp. : 3869-3876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of chronic lymphocytic leukaemia during ipilimumab therapy in a patient with metastatic melanoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1626-1627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1001-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 264-272

John Wiley & Sons Inc

Access to resources Recommend Favorite